# SOM230 Ectopic ACTH-producing Tumors

> **NCT02780882** · PHASE2 · WITHDRAWN · sponsor: **Cedars-Sinai Medical Center**

## Conditions studied

- Ectopic ACTH Syndrome

## Interventions

- **DRUG:** Pasireotide

## Key facts

- **NCT ID:** NCT02780882
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-12
- **Primary completion:** 2018-12
- **Final completion:** 2019-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to stringent inclusion/exclusion criteria, study investigator deemed it not feasible.
- **Last updated:** 2018-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02780882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02780882, "SOM230 Ectopic ACTH-producing Tumors". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02780882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*